The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MagnetisMM-30: A phase 1b, open-label study of elranatamab in combination with iberdomide in patients with relapsed or refractory multiple myeloma (RRMM).
 
Alexander Lesokhin
Honoraria - ITeos Therapeutics; Janssen; Legend Biotech; Pfizer; Sanofi; SVB Leerink; SVB Leerink; Trillium Therapeutics
Consulting or Advisory Role - Arcellx; Pfizer; Trillium Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen Oncology (Inst); Pfizer (Inst); Sanofi (Inst); Trillium Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Serametrix, Inc
 
Jonathan Kaufman
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; Incyte; Sanofi; Sebia
Research Funding - Abbvie/Genentech (Inst); Amgen (Inst); BMS (Inst); BMS (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Heidelberg Pharma (Inst); Janssen (Inst); Novartis (Inst); Sutro Biopharma (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - BMS; Sanofi
 
Ashraf Badros
No Relationships to Disclose
 
Jorge Acosta
Employment - Bristol-Myers Squibb/Celgene
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene
 
Patrick Muller
Employment - Novartis
 
Carolyn Lou
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Ashleigh O'Connell
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Gabriel Afram
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Attaya Suvannasankha
Consulting or Advisory Role - GlaxoSmithKline; Janssen Oncology
Research Funding - BMS (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Regeneron (Inst)
Patents, Royalties, Other Intellectual Property - Novel bone anabolic agent in the treatment of cancer bone metastasis (Inst)